CORPORATE GOVERNANCE OVERVIEW STATEMENT PRINCIPLEA: BOARDLEADERSHIPANDEFFECTIVENESS (CONT’D) In its deliberation and review of the CG Overview Statement, the Board is satisfied that the practices set out in the MCCG as defined in the MCCG, in all material respects, have been applied to achieve the intended outcomes for the financial year under review except for the practices mentioned below: Practice 5.9 : The board comprises at least 30% women directors. The Board of Directors of DRMSB consists of all male directors. Previously the Board had two female Directors. However, both of them had retired in 2020. The board is continuously scouting for at least one woman director to sit on board in 2022, taking into account diverse perspectives and insights based on the candidate’s integrity, independence, diversity in terms of age, gender, cultural background and experience, leadership and ability to exercise sound judgement. Target date for full implementation: June 2023 Practice 8.1 : There is detailed disclosure on named basis for the remuneration of individual directors. The remuneration breakdown of individual directors includes fees, salary, bonus, benefits in-kind and other emoluments. The remuneration of the directors is paid by the Manager and not by the Fund. However, the Board ensures that the remuneration policy takes into account the demands, complexities and performance of the Company as well as skills-set and relevant experiences required. For Independent Directors, the Board ensures that the remuneration does not conflict with their obligation to bring objectivity and independent judgment on matters discussed at the Board meetings. Practice 8.2 : The board discloses on a named basis the top five senior management’s remuneration component including salary, bonus, benefits in-kind and other emoluments in bands of RM50,000. The Board is of the view that such disclosure may not be in the best interest of the Company due to confidentiality and security concerns. The details on the extent of the application of each CG practice as set out in the MCCG including the explanation for non-adoption of or departure from the abovementioned practices, are available in the CG Report for the financial year ended 31 December 2021. 104 AL-`AQAR HEALTHCARE REIT ANNUAL REPORT 2021
RkJQdWJsaXNoZXIy NDgzMzc=